Gil van Bokkelen
Chairman chez The National Center For Regenerative Medicine
Profil
Gil van Bokkelen was the founder of Athersys, Inc. (founded in 1995) where he held the titles of Chairman & Chief Executive Officer from 2000 to 2021.
He is currently the Chairman-Governors Board at The National Center For Regenerative Medicine, Director-Emerging Companies Section at Biotechnology Innovation Organization (since 2014), Director at Regenerative Medicine Foundation (since 2011), and Director at McGowan Institute for Regenerative Medicine.
In the past, he served as Chairman & Chief Executive Officer at BTHC VI, Inc. in 2007, Chairman-Governors Board at Alliance for Regenerative Medicine from 2010 to 2012, Director-Emerging Companies Section at Biotechnology Innovation Organization from 2001 to 2004, and Trustee at Kent State University (Ohio) from 2001 to 2004.
Dr. van Bokkelen received his undergraduate degree from the University of California, Berkeley and his doctorate degree from Stanford University School of Medicine.
Postes actifs de Gil van Bokkelen
| Sociétés | Poste | Début |
|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Corporate Officer/Principal | 19/02/2010 |
Regenerative Medicine Foundation
 Regenerative Medicine Foundation Medical SpecialtiesHealth Technology The Regenerative Medicine Foundation is a non-profit organization that aims to accelerate the development of regenerative medicine to improve health and deliver cures. The non-profit company is based in Winston-Salem, NC. The foundation fosters strategic collaborations to achieve its mission and produces its flagship event, the World Stem Cell Summit. Additionally, the foundation honors leaders in the field through the Stem Cell and Regenerative Medicine Action Awards and promotes educational initiatives. | Director/Board Member | 29/12/2011 |
| The National Center For Regenerative Medicine | Chairman | 08/01/2014 |
| Mcgowan Institute for Regenerative Medicine | Director/Board Member | - |
Anciens postes connus de Gil van Bokkelen
| Sociétés | Poste | Fin |
|---|---|---|
| ATHERSYS, INC. | Chief Executive Officer | 16/02/2021 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Chairman | 31/12/2012 |
| BTHC VI, Inc. | Chairman | 06/09/2007 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Corporate Officer/Principal | 01/01/2004 |
| Kent State University (Ohio) | Director/Board Member | 01/01/2004 |
Formation de Gil van Bokkelen
| University of California, Berkeley | Undergraduate Degree |
| Stanford University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ATHERSYS, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
| BTHC VI, Inc. | Finance |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Bell Biosystems, Inc.
 Bell Biosystems, Inc. BiotechnologyHealth Technology Bell Biosystems, Inc. operates as a synthetic biology company. It develops Magnelle, a synthetic organelle that produces magnetic nanoparticles from intracellular iron, as well as enables to track, control, and destroy transplanted cells in vivo. The firm's product is used in regenerative medicine, oncology, and other cell-based fields. The company was founded by Caleb B. Bell III and Daniel Bell in June 2009 and is headquartered in San Francisco, CA. | Health Technology |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |
Regenerative Medicine Foundation
Regenerative Medicine Foundation Medical SpecialtiesHealth Technology The Regenerative Medicine Foundation is a non-profit organization that aims to accelerate the development of regenerative medicine to improve health and deliver cures. The non-profit company is based in Winston-Salem, NC. The foundation fosters strategic collaborations to achieve its mission and produces its flagship event, the World Stem Cell Summit. Additionally, the foundation honors leaders in the field through the Stem Cell and Regenerative Medicine Action Awards and promotes educational initiatives. | Health Technology |
| The National Center For Regenerative Medicine |
